Gilead Sciences, Inc. (NASDAQ:GILD), a biopharmaceutical company, discovers, develops and commercializes medicines to address unmet medical needs in the United States, Europe and internationally.

After years of demands from shareholders for another major deal, Gilead has made a spectacular move, sealing a deal to acquire cell therapy leader Kite for just under $12 billion. Gilead had been ...

Just a week after dropping the development of its CD47-targeting antibody magrolimab in blood cancers, Gilead Sciences has paused enrolment in clinical trials of the drug in solid tumours ...

Polaris Global Equity Strategy highlighted stocks like Gilead Sciences, Inc. (NASDAQ:GILD), in the third quarter 2024 investor letter. Gilead Sciences, Inc. (NASDAQ:GILD) is a biopharmaceutical ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

In this article, we are going to take a look at where Gilead Sciences, Inc. (NASDAQ:GILD) stands against the other stocks Jim Cramer talked about. Jim Cramer, host of Mad Money, recently shared ...

Rest assured, all imagery and advice is unique and original. Check out how we test and review games here Raven Team Syd is one of the most popular Fortnite skins despite being unreleased for months.

Making your own natural lip balm is not only cost-effective but also a fun and easy DIY project. With the right ingredients, easily found in most African markets, you can create a lip balm that ...

A centuries-old Buddhist model of the universe has new meaning for the shortest of days and longest of worries. By Holland Cotter The Metropolitan Museum of Art is, in these darkest days of ...

In addition, check the fund’s top five holdings to know its best picks in 2024. Polaris Global Equity Strategy highlighted stocks like Gilead Sciences, Inc. (NASDAQ:GILD), in the third quarter 2024 ...